What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His main research concerns Internal medicine, Oncology, Surgery, Colorectal cancer and Chemotherapy.
His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology.
His research integrates issues of Locally advanced, Fluorouracil, Pancreatic disease and Pancreatic ductal adenocarcinoma in his study of Oncology.
His work carried out in the field of Surgery brings together such families of science as Neoadjuvant therapy, Oxaliplatin, FOLFIRINOX and Capecitabine.
The various areas that he examines in his Colorectal cancer study include Bevacizumab, Neoplasm staging, Disease and Adenocarcinoma.
His Chemotherapy study which covers Rectum that intersects with Urology and Progressive disease.
His most cited work include:
- Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (1739 citations)
- The case for knowledge translation: shortening the journey from evidence to effect (587 citations)
- Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors (505 citations)
What are the main themes of his work throughout his whole career to date?
David P. Ryan mainly focuses on Internal medicine, Oncology, Surgery, Colorectal cancer and Cancer.
His Internal medicine study typically links adjacent topics like Gastroenterology.
His biological study spans a wide range of topics, including Pancreatic cancer, Irinotecan, KRAS, Bevacizumab and Adenocarcinoma.
His Surgery research incorporates themes from Tolerability and Capecitabine.
His studies in Colorectal cancer integrate themes in fields like Cancer research, Fluorouracil and Disease.
His Phases of clinical research study integrates concerns from other disciplines, such as Hepatocellular carcinoma and Clinical endpoint.
He most often published in these fields:
- Internal medicine (57.28%)
- Oncology (40.19%)
- Surgery (20.39%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (57.28%)
- Oncology (40.19%)
- Cancer (17.86%)
In recent papers he was focusing on the following fields of study:
David P. Ryan mainly investigates Internal medicine, Oncology, Cancer, Cancer research and Colorectal cancer.
Internal medicine is often connected to Gastroenterology in his work.
He works mostly in the field of Oncology, limiting it down to topics relating to Anal cancer and, in certain cases, Anal canal.
His Cancer research focuses on Depression and how it relates to Anxiety.
His Cancer research research is multidisciplinary, incorporating perspectives in Cyclin-dependent kinase, Phases of clinical research, Pancreatic ductal adenocarcinoma and Immunotherapy.
David P. Ryan has included themes like Overall survival, Circulating tumor DNA, Nuclear medicine and Chemotherapy in his Colorectal cancer study.
Between 2018 and 2021, his most popular works were:
- Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial. (116 citations)
- Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. (102 citations)
- Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study. (48 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
David P. Ryan focuses on Internal medicine, Oncology, Gastroenterology, Cancer research and Cancer.
David P. Ryan integrates several fields in his works, including Internal medicine and In patient.
His Oncology study incorporates themes from FOLFIRINOX, Clinical efficacy, Targeted therapy, Genetic heterogeneity and Autopsy.
While the research belongs to areas of Gastroenterology, he spends his time largely on the problem of Cohort, intersecting his research to questions surrounding Pancreas, Disease, Adenocarcinoma and Resection margin.
His Cancer research research includes themes of Phases of clinical research, Nivolumab, Ipilimumab and Pancreatic ductal adenocarcinoma.
His biological study deals with issues like Chemotherapy, which deal with fields such as Colorectal cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
